James A. Bianco
Chairman at Aequus BioPharma, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jack W. Singer | M | 81 |
Veterans Administration Medical Center
Veterans Administration Medical Center Hospital/Nursing ManagementHealth Services Veterans Administration Medical Center provides healthcare services. The private company is based in San Diego, CA.
Aequus BioPharma, Inc.
Aequus BioPharma, Inc. Medical/Nursing ServicesHealth Services Aequus BioPharma was formed in May 2007 as a majority-owned subsidiary of Cell Therapeutics, Inc. to discover, develop, and market biotherapeutics based upon the proprietary Genetic Polymer technology platform invented at CTI. Its technology addresses many of the traditional problems encountered during the development and commercialization of protein-based biopharmaceuticals. Aequus and CTI are collaborating on the development of AQB-101, a follow-on protein product or biosimilar based upon granulocyte-colony stimulating factor (G-CSF) coupled to a Genetic Polymer carrier domain. The company believe that AQB-101 provides an elegantly simple solution to the plasma half-life and bioavailability issues that have been observed with the original formulations of G-CSF-based biomedicines and which have been addressed by others using traditional chemical modification approaches in their G-CSF-based biosimilars. | 44 years |
Jean-François Heitz | M | 73 |
Seattle Symphony Orchestra
Seattle Symphony Orchestra Movies/EntertainmentConsumer Services The Seattle Symphony Orchestra provides music entertainment. The private company is based in Seattle, WA.
Seattle Symphony Foundation
| - |
Frederick Telling | M | 73 |
Aequus BioPharma, Inc.
Aequus BioPharma, Inc. Medical/Nursing ServicesHealth Services Aequus BioPharma was formed in May 2007 as a majority-owned subsidiary of Cell Therapeutics, Inc. to discover, develop, and market biotherapeutics based upon the proprietary Genetic Polymer technology platform invented at CTI. Its technology addresses many of the traditional problems encountered during the development and commercialization of protein-based biopharmaceuticals. Aequus and CTI are collaborating on the development of AQB-101, a follow-on protein product or biosimilar based upon granulocyte-colony stimulating factor (G-CSF) coupled to a Genetic Polymer carrier domain. The company believe that AQB-101 provides an elegantly simple solution to the plasma half-life and bioavailability issues that have been observed with the original formulations of G-CSF-based biomedicines and which have been addressed by others using traditional chemical modification approaches in their G-CSF-based biosimilars. | 13 years |
Rainer Storb | M | - |
Friends of José Carreras International Leukemia Foundation
| - |
Michael Romy Greer | M | - |
ArtsFund
ArtsFund Miscellaneous Commercial ServicesCommercial Services ArtsFund is a platform that expands the capacity of the cultural sector by sharing resources, practices, and perspectives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. It has a network of affiliated arts and cultural organizations in the central Puget Sound region. ArtsFund collaborates with the Department of Commerce to fund arts capital projects throughout the state, securing over $129 million for 262 capital projects. Since its founding in 1969, ArtsFund has distributed more than $100 million to over 650 arts organization grantees. The CEO of the company is Michael Romy Greer. | - |
Norman Schulman | M | - |
The Leukaemia Foundation
| - |
Stewart D. Chipman | M | - |
Aequus BioPharma, Inc.
Aequus BioPharma, Inc. Medical/Nursing ServicesHealth Services Aequus BioPharma was formed in May 2007 as a majority-owned subsidiary of Cell Therapeutics, Inc. to discover, develop, and market biotherapeutics based upon the proprietary Genetic Polymer technology platform invented at CTI. Its technology addresses many of the traditional problems encountered during the development and commercialization of protein-based biopharmaceuticals. Aequus and CTI are collaborating on the development of AQB-101, a follow-on protein product or biosimilar based upon granulocyte-colony stimulating factor (G-CSF) coupled to a Genetic Polymer carrier domain. The company believe that AQB-101 provides an elegantly simple solution to the plasma half-life and bioavailability issues that have been observed with the original formulations of G-CSF-based biomedicines and which have been addressed by others using traditional chemical modification approaches in their G-CSF-based biosimilars. | - |
Jim Fong | M | 62 | 16 years | |
Ronald Berenson | M | - |
Aequus BioPharma, Inc.
Aequus BioPharma, Inc. Medical/Nursing ServicesHealth Services Aequus BioPharma was formed in May 2007 as a majority-owned subsidiary of Cell Therapeutics, Inc. to discover, develop, and market biotherapeutics based upon the proprietary Genetic Polymer technology platform invented at CTI. Its technology addresses many of the traditional problems encountered during the development and commercialization of protein-based biopharmaceuticals. Aequus and CTI are collaborating on the development of AQB-101, a follow-on protein product or biosimilar based upon granulocyte-colony stimulating factor (G-CSF) coupled to a Genetic Polymer carrier domain. The company believe that AQB-101 provides an elegantly simple solution to the plasma half-life and bioavailability issues that have been observed with the original formulations of G-CSF-based biomedicines and which have been addressed by others using traditional chemical modification approaches in their G-CSF-based biosimilars. | 12 years |
Reed Tuckson | M | 73 | 13 years | |
Robin S. Lineberger | M | - |
The Leukaemia Foundation
| - |
Brian Friedman | M | 68 |
The Leukaemia Foundation
| - |
Carl J. March | M | - |
Aequus BioPharma, Inc.
Aequus BioPharma, Inc. Medical/Nursing ServicesHealth Services Aequus BioPharma was formed in May 2007 as a majority-owned subsidiary of Cell Therapeutics, Inc. to discover, develop, and market biotherapeutics based upon the proprietary Genetic Polymer technology platform invented at CTI. Its technology addresses many of the traditional problems encountered during the development and commercialization of protein-based biopharmaceuticals. Aequus and CTI are collaborating on the development of AQB-101, a follow-on protein product or biosimilar based upon granulocyte-colony stimulating factor (G-CSF) coupled to a Genetic Polymer carrier domain. The company believe that AQB-101 provides an elegantly simple solution to the plasma half-life and bioavailability issues that have been observed with the original formulations of G-CSF-based biomedicines and which have been addressed by others using traditional chemical modification approaches in their G-CSF-based biosimilars. | - |
Robert Sackstein | M | - |
Friends of José Carreras International Leukemia Foundation
| - |
Alberto Grañena | M | - |
Friends of José Carreras International Leukemia Foundation
| - |
Diane Sturiale | F | - |
Friends of José Carreras International Leukemia Foundation
| - |
Beverly Torok-Storb | F | - |
Friends of José Carreras International Leukemia Foundation
| - |
Jody Allen Patton | F | 66 |
ArtsFund
ArtsFund Miscellaneous Commercial ServicesCommercial Services ArtsFund is a platform that expands the capacity of the cultural sector by sharing resources, practices, and perspectives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. It has a network of affiliated arts and cultural organizations in the central Puget Sound region. ArtsFund collaborates with the Department of Commerce to fund arts capital projects throughout the state, securing over $129 million for 262 capital projects. Since its founding in 1969, ArtsFund has distributed more than $100 million to over 650 arts organization grantees. The CEO of the company is Michael Romy Greer. | - |
Cathi Hatch | F | 74 |
Seattle Symphony Orchestra
Seattle Symphony Orchestra Movies/EntertainmentConsumer Services The Seattle Symphony Orchestra provides music entertainment. The private company is based in Seattle, WA. | - |
Christine Baker | F | 58 |
TuHURA Biopharma, Inc.
TuHURA Biopharma, Inc. BiotechnologyHealth Technology TuHURA Biopharma, Inc. operates as a biotechnology company. It develops bifunctional immunoconjugates for the treatment of cancer. The company was founded in 2018 and is headquartered in Seattle,WA. | - |
Jeffrey Kunins | M | 49 |
Seattle Police Foundation
| - |
Aimee Johnson | F | 55 |
Seattle Symphony Foundation
| - |
Sara A. Jones | F | - |
ArtsFund
ArtsFund Miscellaneous Commercial ServicesCommercial Services ArtsFund is a platform that expands the capacity of the cultural sector by sharing resources, practices, and perspectives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. It has a network of affiliated arts and cultural organizations in the central Puget Sound region. ArtsFund collaborates with the Department of Commerce to fund arts capital projects throughout the state, securing over $129 million for 262 capital projects. Since its founding in 1969, ArtsFund has distributed more than $100 million to over 650 arts organization grantees. The CEO of the company is Michael Romy Greer. | - |
Patrice M. Auld | F | - |
Seattle Symphony Orchestra
Seattle Symphony Orchestra Movies/EntertainmentConsumer Services The Seattle Symphony Orchestra provides music entertainment. The private company is based in Seattle, WA. | - |
Kumi Baruffi | F | 53 |
ArtsFund
ArtsFund Miscellaneous Commercial ServicesCommercial Services ArtsFund is a platform that expands the capacity of the cultural sector by sharing resources, practices, and perspectives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. It has a network of affiliated arts and cultural organizations in the central Puget Sound region. ArtsFund collaborates with the Department of Commerce to fund arts capital projects throughout the state, securing over $129 million for 262 capital projects. Since its founding in 1969, ArtsFund has distributed more than $100 million to over 650 arts organization grantees. The CEO of the company is Michael Romy Greer. | - |
David Cosman | M | - |
Aequus BioPharma, Inc.
Aequus BioPharma, Inc. Medical/Nursing ServicesHealth Services Aequus BioPharma was formed in May 2007 as a majority-owned subsidiary of Cell Therapeutics, Inc. to discover, develop, and market biotherapeutics based upon the proprietary Genetic Polymer technology platform invented at CTI. Its technology addresses many of the traditional problems encountered during the development and commercialization of protein-based biopharmaceuticals. Aequus and CTI are collaborating on the development of AQB-101, a follow-on protein product or biosimilar based upon granulocyte-colony stimulating factor (G-CSF) coupled to a Genetic Polymer carrier domain. The company believe that AQB-101 provides an elegantly simple solution to the plasma half-life and bioavailability issues that have been observed with the original formulations of G-CSF-based biomedicines and which have been addressed by others using traditional chemical modification approaches in their G-CSF-based biosimilars. | - |
Stephen P. Reynolds | M | 76 |
ArtsFund
ArtsFund Miscellaneous Commercial ServicesCommercial Services ArtsFund is a platform that expands the capacity of the cultural sector by sharing resources, practices, and perspectives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. It has a network of affiliated arts and cultural organizations in the central Puget Sound region. ArtsFund collaborates with the Department of Commerce to fund arts capital projects throughout the state, securing over $129 million for 262 capital projects. Since its founding in 1969, ArtsFund has distributed more than $100 million to over 650 arts organization grantees. The CEO of the company is Michael Romy Greer. | - |
Darren R. Hamby | M | 58 |
ArtsFund
ArtsFund Miscellaneous Commercial ServicesCommercial Services ArtsFund is a platform that expands the capacity of the cultural sector by sharing resources, practices, and perspectives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. It has a network of affiliated arts and cultural organizations in the central Puget Sound region. ArtsFund collaborates with the Department of Commerce to fund arts capital projects throughout the state, securing over $129 million for 262 capital projects. Since its founding in 1969, ArtsFund has distributed more than $100 million to over 650 arts organization grantees. The CEO of the company is Michael Romy Greer. | - |
Mary Giovingo | F | - |
The Leukaemia Foundation
| - |
SoYoung Kwon | F | 56 |
Seattle Symphony Orchestra
Seattle Symphony Orchestra Movies/EntertainmentConsumer Services The Seattle Symphony Orchestra provides music entertainment. The private company is based in Seattle, WA. | - |
Joshua Green | M | 87 |
ArtsFund
ArtsFund Miscellaneous Commercial ServicesCommercial Services ArtsFund is a platform that expands the capacity of the cultural sector by sharing resources, practices, and perspectives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. It has a network of affiliated arts and cultural organizations in the central Puget Sound region. ArtsFund collaborates with the Department of Commerce to fund arts capital projects throughout the state, securing over $129 million for 262 capital projects. Since its founding in 1969, ArtsFund has distributed more than $100 million to over 650 arts organization grantees. The CEO of the company is Michael Romy Greer. | - |
Stephen J. Rotella | M | 70 |
ArtsFund
ArtsFund Miscellaneous Commercial ServicesCommercial Services ArtsFund is a platform that expands the capacity of the cultural sector by sharing resources, practices, and perspectives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. It has a network of affiliated arts and cultural organizations in the central Puget Sound region. ArtsFund collaborates with the Department of Commerce to fund arts capital projects throughout the state, securing over $129 million for 262 capital projects. Since its founding in 1969, ArtsFund has distributed more than $100 million to over 650 arts organization grantees. The CEO of the company is Michael Romy Greer. | - |
Jill S. Ruckelshaus | F | 86 |
Seattle Symphony Orchestra
Seattle Symphony Orchestra Movies/EntertainmentConsumer Services The Seattle Symphony Orchestra provides music entertainment. The private company is based in Seattle, WA. | - |
Laura L. Neebling | F | - |
ArtsFund
ArtsFund Miscellaneous Commercial ServicesCommercial Services ArtsFund is a platform that expands the capacity of the cultural sector by sharing resources, practices, and perspectives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. It has a network of affiliated arts and cultural organizations in the central Puget Sound region. ArtsFund collaborates with the Department of Commerce to fund arts capital projects throughout the state, securing over $129 million for 262 capital projects. Since its founding in 1969, ArtsFund has distributed more than $100 million to over 650 arts organization grantees. The CEO of the company is Michael Romy Greer. | 16 years |
Howard Lincoln | M | - |
ArtsFund
ArtsFund Miscellaneous Commercial ServicesCommercial Services ArtsFund is a platform that expands the capacity of the cultural sector by sharing resources, practices, and perspectives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. It has a network of affiliated arts and cultural organizations in the central Puget Sound region. ArtsFund collaborates with the Department of Commerce to fund arts capital projects throughout the state, securing over $129 million for 262 capital projects. Since its founding in 1969, ArtsFund has distributed more than $100 million to over 650 arts organization grantees. The CEO of the company is Michael Romy Greer. | - |
George Christopher Pagos | M | 74 |
ArtsFund
ArtsFund Miscellaneous Commercial ServicesCommercial Services ArtsFund is a platform that expands the capacity of the cultural sector by sharing resources, practices, and perspectives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. It has a network of affiliated arts and cultural organizations in the central Puget Sound region. ArtsFund collaborates with the Department of Commerce to fund arts capital projects throughout the state, securing over $129 million for 262 capital projects. Since its founding in 1969, ArtsFund has distributed more than $100 million to over 650 arts organization grantees. The CEO of the company is Michael Romy Greer. | - |
Marco Argenti | M | - |
Seattle Symphony Orchestra
Seattle Symphony Orchestra Movies/EntertainmentConsumer Services The Seattle Symphony Orchestra provides music entertainment. The private company is based in Seattle, WA. | - |
Christopher J. Voss | M | - |
Seattle Symphony Orchestra
Seattle Symphony Orchestra Movies/EntertainmentConsumer Services The Seattle Symphony Orchestra provides music entertainment. The private company is based in Seattle, WA. | - |
George W. Rowley | M | 82 |
ArtsFund
ArtsFund Miscellaneous Commercial ServicesCommercial Services ArtsFund is a platform that expands the capacity of the cultural sector by sharing resources, practices, and perspectives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. It has a network of affiliated arts and cultural organizations in the central Puget Sound region. ArtsFund collaborates with the Department of Commerce to fund arts capital projects throughout the state, securing over $129 million for 262 capital projects. Since its founding in 1969, ArtsFund has distributed more than $100 million to over 650 arts organization grantees. The CEO of the company is Michael Romy Greer. | - |
Michael J. Malone | M | 79 |
Seattle Police Foundation
| - |
Robert Cremin | M | 83 |
Seattle Symphony Orchestra
Seattle Symphony Orchestra Movies/EntertainmentConsumer Services The Seattle Symphony Orchestra provides music entertainment. The private company is based in Seattle, WA. | - |
Gregory Steinhauer | M | - |
Seattle Police Foundation
| - |
Connections Chart
Multi-company connection
Former connections
Statistics
Country | Connections | % of total |
---|---|---|
United States | 79 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- James A. Bianco
- Personal Network